ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,702.12
      0.33%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. XOMA Corporation (XOMAP)

      7. XOMA Corporation (XOMAP) News

      XOMAP XOMA Corporation

      25.31
      0.00 (0.00%)
      May 31 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      XOMA Corporation XOMAP NASDAQ Preference Share
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 25.31 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      25.31 25.31
      more quote information »

      Recent News

      Date Time Source Heading
      5/30/202416:43EDGAR2Form 8-K - Current report
      5/17/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/17/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/17/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/17/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/17/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/17/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/16/202407:31EDGAR2Form 8-K - Current report
      5/14/202407:30GLOBEXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect..
      5/09/202407:45EDGAR2Form 8-K - Current report
      5/09/202407:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      5/09/202407:30GLOBEXOMA Reports First Quarter 2024 Financial Results and..
      4/30/202407:30GLOBEXOMA Adds Economic Interests in Three First-in-Category..
      4/25/202407:30GLOBEXOMA Earns $9 Million Milestone as FDA Grants Accelerated..
      4/03/202409:00GLOBEXOMA Corporation Announces Closing of Tender Offer
      3/21/202407:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
      3/19/202416:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
      3/11/202406:56EDGAR2Form S-4 - Registration of securities, business combinations
      3/08/202416:34EDGAR2Form S-3 - Registration statement under Securities Act of..
      3/08/202407:39EDGAR2Form 8-K - Current report
      3/08/202407:30GLOBEXOMA Reports Fourth Quarter and Full Year 2023 Financial..
      3/04/202417:24EDGAR2Form SC TO-T - Tender offer statement by Third Party
      2/28/202407:30GLOBEXOMA to Present at Upcoming Investor Conferences in March
      2/16/202409:08EDGAR2Form 8-K - Current report
      2/16/202408:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
      1/18/202408:30GLOBEXOMA Expands its Commercial Royalty and Milestone Portfolio..
      1/16/202417:22EDGAR2Form SC 13D/A - General statement of acquisition of..
      1/11/202416:31EDGAR2Form 8-K - Current report
      1/11/202416:05GLOBEFDA Acceptance of Zevra’s Arimoclomol NDA Filing for..
      1/10/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202407:30GLOBEXOMA Names Owen Hughes as Chief Executive Officer and..
      1/02/202407:46EDGAR2Form 8-K - Current report
      1/02/202407:30GLOBEXOMA Announces Stock Repurchase Program of up to $50 Million
      12/20/202307:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
      12/19/202307:40EDGAR2Form 8-K - Current report
      12/19/202307:30GLOBEXOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse..
      11/07/202307:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/07/202307:40EDGAR2Form 8-K - Current report
      11/07/202307:30GLOBEXOMA Reports Third Quarter 2023 Financial Results and..
      10/31/202307:35EDGAR2Form 8-K - Current report
      10/31/202307:30GLOBEXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day..
      10/27/202317:06EDGAR2Form 8-K - Current report
      10/04/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/04/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/27/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/25/202307:30GLOBEXOMA Declares Quarterly Preferred Stock Dividends
      9/11/202316:10EDGAR2Form 8-K - Current report
      9/06/202307:30GLOBEXOMA to Present at H.C. Wainwright 25th Annual Global..
      8/25/202317:09EDGAR2Form 8-K - Current report
      8/08/202307:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      Your Recent History

      NASDAQ
      XOMAP
      XOMA
      USOTC
      DRVYF
      Discovery Alaska (GM)
      KOSPI
      700019
      Bloomberg Leverage Natur...
      Delayed Upgrade Clock